Lauren Santye, Assistant Editor

Viagra and other PDE5 inhibitors found safe as long as men are not also taking nitrates.

Indication for the treatment of adults and pediatric patients with solid tumors containing MSI-H or dMMR.

Pembrolizumab targets the PD-1/PD-L1 cellular pathway to help the immune system fight cancer cells.

No evidence found that erectile dysfunction drugs cause melanoma.

Study provides picture of host cell pathway mobilization to HCV.

Top news of the day from across the health care landscape.

Top news of the day from across the healthcare landscape.

Sarilumab plus DMARDs demonstrated statistically significant improvements in patients with moderate to severe RA.

Sarilumab is a human monoclonal antibody designed to bind to the interleukin-6 receptor.

The continuum of HIV care enables countries to monitor the success of their HIV response, from diagnosis to viral suppression.

Sheila Arquette, RPh, director of Pharmacy Services at Independent Health, discusses how specialty stakeholders can improve clinical and financial alignment.

Non-EU and EEA countries trail behind in reaching viral suppression target by 2020.

Top news of the day from across the health care landscape.

Top news of the day from across the healthcare landscape.

Nanoparticle vaccines can travel directly to the lymph nodes to activate tumor-specific immune responses.

In a study published in Nature Medicine, investigators found that when a virus enters the bloodstream it activates the first responder immune cells, CX3CR1highLY6Clow monocytes.

Virus-driven immune activation blocks connections between nerve cells in the brain.

A novel AI image detection method could potentially outperform current PAP and HPV tests.

Top news of the day from across the health care landscape.

Keytruda demonstrated statistically significant improvements in overall survival.

Pembrolizumab shows statistically significant improvements in overall survival and objective response rate in cancer treatment.

The criminalization of drug use could be detrimental to HIV patient health and does not decrease use, study suggests.

Southern Italy tomato varieties demonstrated a potential role against typical neoplastic features.

Top news of the day from across the health care landscape.

Jonathan Van Lare, PharmD, director of Pharmacy Advantage, discusses the growth of biosimilars in specialty pharmacy.

The approval triples the number of rare gene mutations that ivacaftor can now treat.

Consumption of soy may mitigate markers of colonic inflammation.

Top news of the day from across the health care landscape.

Nanoparticle precisely delivers tumor antigens to immune cells while stimulating immunity.

Investing in diagnostic resources, prevention, and treatment programs are vital to ending the HIV epidemic in the United States.